Literature DB >> 10728756

Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.

K Yudoh1, H Matsuno, F Nakazawa, T Yonezawa, T Kimura.   

Abstract

OBJECTIVE: To elucidate the involvement of the regulatory CD4+ T cells that produce high levels of interleukin-10 (IL-10) and low levels of IL-4 and IL-2 in the pathogenesis of rheumatoid arthritis (RA), we investigated whether the frequency of this type of CD4+ T cell subset in peripheral blood lymphocytes (PBL) or synovial lymphocyte infiltrates of patients with RA correlated with disease severity and histologic features in rheumatoid synovium.
METHODS: PBL and synovial lymphocyte infiltrates were isolated from peripheral blood samples and synovial tissues obtained from 25 patients with RA. Control specimens were obtained from 18 patients with osteoarthritis (OA) and 10 patients with traumatic injuries of the knee joint. CD4+ T cell subsets were categorized as Th1 (production of interferon-gamma [IFNgamma], but not IL-4), Th2 (production of IL-4, but not IFNgamma), or CD4+ T cell subsets producing IL-10, IL-2, or IL-4. The percentages of these T helper subsets among PBL and among synovial infiltrating lymphocytes were determined by an intracellular staining assay with flow cytometric analysis.
RESULTS: The level of expression of CD4+ T cells producing IL-10 but not IL-2 and IL-4 in the peripheral blood and synovial tissue was significantly lower in RA patients than in OA patients and trauma patients. In RA patients, the frequency of this type of CD4+ T cell subset among synovial infiltrating CD4+ T cells was inversely correlated with the frequency of Th1 cells and the Th1/Th2 balance in synovial lymphocytes, serum C-reactive protein value, disease activity score, and the degree of synovial lining hyperplasia and lymphocyte infiltration in rheumatoid synovium. There was a reciprocal relationship between the frequency of Thl cells and CD4+ T cells producing IL-10 but not IL-2 and IL-4 in the peripheral blood of RA patients.
CONCLUSION: In RA, reduced expression of the CD4+ T cell subset producing IL-10 but not IL-2 and IL-4 may be responsible for the dominance of Th1 over Th2 cells at sites of inflamed synovium and in the peripheral blood. Decreases in this type of CD4+ T cell subset may induce the down-regulation of T cell tolerance and exacerbate the inflammatory process in RA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728756     DOI: 10.1002/1529-0131(200003)43:3<617::AID-ANR19>3.0.CO;2-B

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  40 in total

Review 1.  Th2 mediated regulation in RA and the spondyloarthropathies.

Authors:  J A G van Roon; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis.

Authors:  Mary Canavan; Alice M Walsh; Vipul Bhargava; Sarah M Wade; Trudy McGarry; Viviana Marzaioli; Barry Moran; Monika Biniecka; Hannah Convery; Siobhan Wade; Carl Orr; Ronan Mullan; Jean M Fletcher; Sunil Nagpal; Douglas J Veale; Ursula Fearon
Journal:  JCI Insight       Date:  2018-12-06

3.  Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis.

Authors:  Shiqian Shen; Junghee J Shin; Klemen Strle; Gail McHugh; Xin Li; Lisa J Glickstein; Elise E Drouin; Allen C Steere
Journal:  Arthritis Rheum       Date:  2010-07

4.  Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells.

Authors:  Elena Gonzalez-Rey; Alejo Chorny; Francisco O'Valle; Mario Delgado
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 5.  Regulatory T cells in rheumatoid arthritis.

Authors:  Sujata Sarkar; David A Fox
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

6.  Immunomodulatory Effects of Curcumin in Rheumatoid Arthritis: Evidence from Molecular Mechanisms to Clinical Outcomes.

Authors:  Saeed Mohammadian Haftcheshmeh; Arezou Khosrojerdi; Ali Aliabadi; Shadi Lotfi; Asadollah Mohammadi; Amir Abbas Momtazi-Borojeni
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

7.  The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

8.  Use of immune modulation by human adipose-derived mesenchymal stem cells to treat experimental arthritis in mice.

Authors:  Li Zhang; Xiao-Yan Wang; Peng-Jun Zhou; Zhe He; Hai-Zhao Yan; Dan-Dan Xu; Ying Wang; Wu-Yu Fu; Bi-Bo Ruan; Sheng Wang; Hai-Xuan Chen; Qiu-Ying Liu; Yu-Xia Zhang; Zhong Liu; Yi-Fei Wang
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

9.  Dual biological functions of an interleukin-1 receptor antagonist-interleukin-10 fusion protein and its suppressive effects on joint inflammation.

Authors:  Deh-Ming Chang; Song-Kun Shyue; Shao-Hsiang Liu; Yen-Teen Chen; Chiou-Yueh Yeh; Jenn-Huang Lai; Herng-Sheng Lee; Ann Chen
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

10.  Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension.

Authors:  Silvia Ulrich; Mark R Nicolls; Laima Taraseviciene; Rudolf Speich; Norbert Voelkel
Journal:  Respiration       Date:  2007-11-20       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.